Submitted by Anonymous (not verified) on 22 September 2023 - 8:27
Human medicines European public assessment report (EPAR): Tenkasi (previously Orbactiv), oritavancin, Soft Tissue Infections;Skin Diseases, Bacterial, Date of authorisation: 19/03/2015, Revision: 14, Status: Authorised
Source: